Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership129,278 shares
Latest Disclosed Value $ 1,869,359
Franklin Resources Inc reports 40.72% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 129,278 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $1,869,360 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 91,869 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 40.72% during the quarter. The current value of the position is $1,873,238 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 129,278 37,409 40.72 1,869 42.89 0.0001
2026-02-11 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 91,869 35,330 62.49 1,308 193.93 0.0003
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 56,539 21,544 61.56 446 122.50 0.0001
2025-08-12 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 34,995 9,827 39.05 201 -2.44 0.0001
2025-05-13 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 25,168 0 0.00 205 -13.50 0.0001
2025-02-12 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 25,168 -33 -0.13 237 -9.54 0.0001
2024-11-27 2024-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 25,201 252 1.01 263 6.07 0.0001
2024-11-12 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 25,201 252 263 0.0000
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 24,949 30 0.12 247 -15.70 0.0001
2024-05-13 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 24,919 -30,024 -54.65 294 -62.39 0.0001
2024-02-09 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 54,943 1,258 2.34 780 19.48 0.0004
2023-11-13 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 53,685 2,163 4.20 653 0.77 0.0003
2023-08-11 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 51,522 51,522 647 0.0003
2023-02-10 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -12,277 -100.00 0 -100.00
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 12,277 12,277 129 0.0001
2020-05-13 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -1,388,035 -100.00 0 -100.00
2020-03-11 2019-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 1,388,035 -1,345,602 -49.22 13,519 -38.34 0.0071
2020-02-12 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,388,035 -1,345,602 13,519 1,707.6348
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,733,637 -75,791 -2.70 21,924 -37.47 0.0119
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,809,428 -266,682 -8.67 35,062 -16.19 0.0186
2019-05-15 2019-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 3,076,110 10,504 0.34 41,835 42.45 0.0224
2019-05-14 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,076,110 10,504 41,835
2019-02-12 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,065,606 -433,275 -12.38 29,369 -30.57 0.0177
2018-11-13 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,498,881 -536,552 -13.30 42,302 -32.89 0.0211
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 4,035,433 268,044 7.11 63,033 11.25 0.0323
2018-05-10 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,767,389 48,490 1.30 56,661 5.88 0.0287
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,718,899 406,499 12.27 53,515 7.13 0.0257
2017-11-13 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,312,400 1,426,100 75.60 49,951 162.97 0.0245
2017-08-10 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,886,300 0 0.00 18,995 41.24 0.0095
2017-05-12 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,886,300 0 0.00 13,449 43.46 0.0068
2017-02-14 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,886,300 -83,200 -4.22 9,375 -35.67 0.0049
2016-11-14 2016-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,969,500 0 0.00 14,574 35.53 0.0076
2016-08-11 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,969,500 0 0.00 10,753 -35.39 0.0058
2016-05-10 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,969,500 0 0.00 16,642 -12.89 0.0088
2016-04-27 2015-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 1,969,500 763,600 63.32 19,104 13.24 0.0097
2016-02-12 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,969,500 19,104
2015-11-10 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,205,900 -601,500 -33.28 16,871 -34.03 0.0083
2015-08-12 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,807,400 -147,000 -7.52 25,575 20.27 0.0116
2015-05-14 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,954,400 0 0.00 21,264 30.77 0.0096
2015-02-10 2014-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,954,400 81,300 4.34 16,261 45.90 0.0074
2014-11-12 2014-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,873,100 1,873,100 11,145 0.0051
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.